Error message

Please note: Our system will be undergoing maintenance on Thursday, May 25th , 8:30 AM ET, through Monday, June 5th , 12:30 PM ET, During this time, SFB login and transaction-related services will be down. Should you have any urgent issues, please reach out directly to info@biomaterials.org. Thank you!

SFB News

SFB Member Jian Yang, PhD gets FDA Approval for ElaSkin

Aleo BME, a biomaterials and medical device company, has received notification from the U.S. Federal Drug Administration that it has been approved for the sale and licensing of ElaSkinTM as a liquid bandage for the protection and treatment of a broad set of skin conditions and injuries.   Aleo BME is a start-up developing nature-inspired biomaterials to address unmet challenges in the fields...

Read more

AIMBE News

Tags:
AIMBE, Biomaterials

SFB is a proud member of the AIMBE Council of Societies.  AIMBE (American Insitute for Medical and Biological Engineering) is the authoritative voice and advocate for the value of medical and biological engineering to society. 

Click here for the latest edition of ...

Read more

Nanovis Announces FDA Clearance of FortiCore® PLIF and TLIF Spinal Interbodies with Nanosurface Features

Spinal Implants Cleared with the Most Advanced Nanosurface and Best Imaging

On March 28, 2018, Nanovis announced the successful FDA clearance of its FortiCore® TLIF and PLIF interbodies featuring a Nanosurface-enhanced deeply porous titanium scaffold intermolded with a PEEK core. The initial launch of the expanded FortiCore® wedge-shaped cervical cage occurred...

Read more

SFB Member Guillermo Ameer making news!

The Society For Biomaterials is happy to announce that our members continue to make the news!  One of our longstanding members, Guillermo Ameer, ScD, Nortwestern University, has two high profile articles in recent publications we wanted to share with you. First, an article entitled “3D...

Read more

April 30th Book Release: Immune Aspects of Biopharmaceuticals and Nanomedicines

SFB’s Past President and current Board Member, Thomas J. Webster, MS, PhD, has co-authored the Immune Aspects of Biopharmaceuticals and Nanomedicines. With an April 30, 2018 release date, it “provides a broad survey of various topics pertaining to the immune effects of biopharmaceuticals and nanomedicines, both beneficial and adverse. An essential reference for the novice and expert alike in...

Read more